Statistical analyses The primary analysis estimand was the average treatment effect on the treated (ATT), estimated using a propensity score (PS) weighting approach in the on-treatment cohort
All patients taking Semaglutide injections lost more or less 5% of their initial starting weight within these 56 weeks
A similar case was brought by the United States, on behalf of the Department of Defense, against Mihir Taneja alleging over 4,000 fraudulent claims to TRICARE, totaling approximately $19 million in payments
Compared to its closest competitors, AbbVie, Merck, and Celgene, Gileads financials and assets appear in good working order, and its pipeline comprises several late-stage product candidates for high value indications, namely cancer, heart disease, and HIV